Sector
PharmaceuticalsOpen
₹73.1Prev. Close
₹73.1Turnover(Lac.)
₹0.04Day's High
₹75.97Day's Low
₹7352 Week's High
₹104.7552 Week's Low
₹62.35Book Value
₹36.08Face Value
₹10Mkt Cap (₹ Cr.)
22.3P/E
25.72EPS
2.9Divi. Yield
027 Aug 2024
12:00 AM
AGM
Announcement Date: 27 Aug, 2024
10 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6.93 | 6.18 | 5.61 | 4.8 |
Net Worth | 9.92 | 9.17 | 8.6 | 7.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 13.94 | 14.83 | 6.84 | 6.43 |
yoy growth (%) | -5.95 | 116.75 | 6.26 | -9.32 |
Raw materials | -10.28 | -11.44 | -4.73 | -3.97 |
As % of sales | 73.74 | 77.16 | 69.16 | 61.68 |
Employee costs | -1.09 | -1.09 | -0.79 | -0.69 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1.05 | 0.71 | 0.32 | 0.25 |
Depreciation | -0.14 | -0.17 | -0.13 | -0.13 |
Tax paid | -0.22 | -0.16 | -0.07 | -0.07 |
Working capital | 2.9 | -1.04 | -0.26 | -1.4 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -5.95 | 116.75 | 6.26 | -9.32 |
Op profit growth | 20.26 | 92.91 | 9.73 | 31.17 |
EBIT growth | 45.07 | 71.67 | 44.5 | 21.42 |
Net profit growth | 51.63 | 120.78 | 35.8 | 33.01 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Jagdish Agrawal
Non Executive Director
Abha Agrawal
Director
Arvind Sapkal
Company Sec. & Compli. Officer
Srushti Pandya
Independent Director
Dhwani Jaypalsinh Solanki
Survey No 179/1 Taluka Sanand,
Village Vasna-Iyava,
Gujarat - 382170
Tel: -
Website: http://www.ishitadrugs.com
Email: ishitadrugs@vsnl.net
E-2/3 Saki Vihar Rd,
Ansa Indl Estate, Saki Naka Andheri-E,
Mumbai - 400 072
Tel: 91-22-40430200
Website: www.bigshareonline.com
Email: info@bigshareonline.com
Summary
Ishita Drugs & Industries Limited was incorporated in Feb.92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and ...
Read More
Reports by Ishita Drugs & Industries Ltd
What is the Ishita Drugs & Industries Ltd share price today?
What is the Market Cap of Ishita Drugs & Industries Ltd?
What is the PE and PB ratio of Ishita Drugs & Industries Ltd?
What is the 52 Week High and Low of Ishita Drugs & Industries Ltd?
What is the CAGR of Ishita Drugs & Industries Ltd?
What is the shareholding pattern of Ishita Drugs & Industries Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.